Tenet Healthcare (NYSE:THC) Stock Price Expected to Rise, Barclays Analyst Says

Tenet Healthcare (NYSE:THC) had its price objective lifted by equities research analysts at Barclays from $271.00 to $297.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price objective indicates a potential upside of 2.54% from the company’s previous close.

THC has been the subject of a number of other reports. Zacks Research downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 29th. Robert W. Baird increased their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a report on Tuesday, July 28th. The Goldman Sachs Group restated a “buy” rating and set a $305.00 target price on shares of Tenet Healthcare in a report on Tuesday, July 28th. Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research report on Friday, October 2nd. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $293.48.

Tenet Healthcare Stock Up 8.6%

Shares of THC traded up $22.94 during midday trading on Wednesday, reaching $289.63. 1,112,848 shares of the stock were exchanged, compared to its average volume of 1,120,621. The company has a market cap of $23.05 billion, a price-to-earnings ratio of 8.40, a P/E/G ratio of 1.44 and a beta of 1.20. The firm has a 50 day simple moving average of $264.37 and a 200-day simple moving average of $221.04. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76. Tenet Healthcare has a 12-month low of $157.58 and a 12-month high of $292.50.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share for the quarter, beating the consensus estimate of $4.68 by $1.96. The business had revenue of $6.28 billion for the quarter, compared to analyst estimates of $5.49 billion. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The firm’s revenue was up 6.5% on a year-over-year basis. During the same period in the previous year, the business earned $3.70 EPS. Research analysts forecast that Tenet Healthcare will post 22.31 EPS for the current year.

Insider Transactions at Tenet Healthcare

In other news, EVP Lisa Foo sold 24,000 shares of the stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the completion of the transaction, the executive vice president directly owned 8,053 shares of the company’s stock, valued at $2,144,674.96. This represents a 74.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Tammy Romo sold 4,922 shares of the firm’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $264.15, for a total value of $1,300,146.30. Following the sale, the director owned 30,784 shares in the company, valued at $8,131,593.60. The trade was a 13.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 105,884 shares of company stock valued at $28,740,455. Corporate insiders own 0.97% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Manning & Napier Advisors LLC bought a new stake in Tenet Healthcare during the second quarter valued at about $168,761,000. Bank of New York Mellon Corp bought a new position in shares of Tenet Healthcare during the 2nd quarter valued at approximately $106,342,000. Arrowstreet Capital Limited Partnership grew its stake in shares of Tenet Healthcare by 57.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock worth $126,757,000 after buying an additional 244,901 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its stake in Tenet Healthcare by 535.9% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 127,677 shares of the company’s stock worth $24,094,000 after acquiring an additional 107,600 shares during the last quarter. Finally, Wedge Capital Management L L P NC raised its holdings in Tenet Healthcare by 37.6% during the 2nd quarter. Wedge Capital Management L L P NC now owns 221,453 shares of the company’s stock valued at $41,429,000 after buying an additional 60,478 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Key Headlines Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Truist Financial reaffirmed its Buy rating and raised its price target to $305 from $290, signaling continued confidence in Tenet’s prospects. Truist rating coverage
• Positive Sentiment: KeyCorp lifted its target to $300 from $270 and maintained an Overweight rating, adding to the recent run of bullish analyst revisions. KeyCorp target update
• Positive Sentiment: Leerink Partners raised its target to $342 from $309 and kept an Outperform rating. A separate report says Tenet raised its 2026 EBITDA outlook, a potentially important sign of improving earnings expectations. Tenet outlook report
• Positive Sentiment: Wells Fargo and Royal Bank of Canada are also reported to expect further share-price appreciation, adding to the broadly favorable analyst sentiment. Wells Fargo analyst report RBC analyst report
• Neutral Sentiment: Zacks noted increased investor interest in THC but did not provide a specific new catalyst or recommendation in the available article details. Zacks article

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.